arrow
C

Caio de Assis Moura Tavares

Hospital Israelita Albert Einstein
H指数:8
被引数:415

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale , design and baseline characteristics of the OPTIMAL-DIABETES randomized trial

强化血压控制以预防2型糖尿病患者主要心血管事件:OPTIMAL-DIABETES随机试验的原理、设计与基线特征

2026-08-010
PRE
Safety and outcomes of dapagliflozin initiation in critically ill patients with acute kidney injury: A post-hoc analysis of the defender trial

达格列净在急性肾损伤危重患者中起始使用的安全性与结局:defender试验的事后分析

2026-07-010
OAAI
Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical Trial

恩格列净在经体外循环冠状动脉旁路移植术的2型糖尿病患者中的应用:POST-CABGDM随机临床试验

2025-04-150
PRE
Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
2024-01-010
OAAI
The Impact of Frailty on the Relationship between Life-Space Mobility and Quality of Life in Older Adults During the COVID-19 Pandemic

新型冠状病毒肺炎大流行期间虚弱对老年人生活空间流动性与生活质量之间关系的影响

2021-04-0153
OAAI